Cargando…
ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment
Advanced ovarian cancer usually spreads to the omentum. However, the omental cell-derived molecular determinants modulating its progression have not been thoroughly characterized. Here, we show that circulating ITLN1 has prognostic significance in patients with advanced ovarian cancer. Further studi...
Autores principales: | Au-Yeung, Chi-Lam, Yeung, Tsz-Lun, Achreja, Abhinav, Zhao, Hongyun, Yip, Kay-Pong, Kwan, Suet-Ying, Onstad, Michaela, Sheng, Jianting, Zhu, Ying, Baluya, Dodge L., Co, Ngai-Na, Rynne-Vidal, Angela, Schmandt, Rosemarie, Anderson, Matthew L., Lu, Karen H., Wong, Stephen T. C., Nagrath, Deepak, Mok, Samuel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363861/ https://www.ncbi.nlm.nih.gov/pubmed/32669559 http://dx.doi.org/10.1038/s41467-020-17383-2 |
Ejemplares similares
-
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression
por: Kwan, Suet-Ying, et al.
Publicado: (2020) -
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
por: Au Yeung, Chi Lam, et al.
Publicado: (2016) -
Characterization of an intelectin-1 (Itln1) knockout mouse model
por: Nonnecke, Eric B., et al.
Publicado: (2022) -
Human intelectin-1 (ITLN1) genetic variation and intestinal expression
por: Nonnecke, Eric B., et al.
Publicado: (2021) -
Human intelectin‐2 (ITLN2) is selectively expressed by secretory Paneth cells
por: Nonnecke, Eric B., et al.
Publicado: (2022)